Central Nervous System Biomarkers Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: CC71D30859B2EN
Market Monitor Global

Abstracts

With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological conditions.

This report contains market size and forecasts of Central Nervous System Biomarkers in Global, including the following market information:

Global Central Nervous System Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Central Nervous System Biomarkers market was valued at 3974.4 million in 2021 and is projected to reach US$ 5837.8 million by 2028, at a CAGR of 5.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Safety Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Central Nervous System Biomarkers include Merck, Takeda Pharmaceutical, Thermo Fisher Scientific, Avacta Group, Diagenic Asa, Banyan Biomarkers, Eli Lilly, Pfizer and Alseres Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Central Nervous System Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Central Nervous System Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Central Nervous System Biomarkers Market Segment Percentages, by Type, 2021 (%)

• Safety Biomarker
• Efficacy Biomarker
• Validation Biomarker
• Other

Global Central Nervous System Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Central Nervous System Biomarkers Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Central Nervous System Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Central Nervous System Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Central Nervous System Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Central Nervous System Biomarkers revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Takeda Pharmaceutical
• Thermo Fisher Scientific
• Avacta Group
• Diagenic Asa
• Banyan Biomarkers
• Eli Lilly
• Pfizer
• Alseres Pharmaceuticals
• Acumen pharmaceuticals
• EKF Diagnostics
• Abiant
• Myriad RBM
• Aposense

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Central Nervous System Biomarkers Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Central Nervous System Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CENTRAL NERVOUS SYSTEM BIOMARKERS OVERALL MARKET SIZE

2.1 Global Central Nervous System Biomarkers Market Size: 2021 VS 2028
2.2 Global Central Nervous System Biomarkers Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Central Nervous System Biomarkers Players in Global Market
3.2 Top Global Central Nervous System Biomarkers Companies Ranked by Revenue
3.3 Global Central Nervous System Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Central Nervous System Biomarkers Companies in Global Market, by Revenue in 2021
3.5 Global Companies Central Nervous System Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Central Nervous System Biomarkers Players in Global Market
  3.6.1 List of Global Tier 1 Central Nervous System Biomarkers Companies
  3.6.2 List of Global Tier 2 and Tier 3 Central Nervous System Biomarkers Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Central Nervous System Biomarkers Market Size Markets, 2021 & 2028
  4.1.2 Safety Biomarker
  4.1.3 Efficacy Biomarker
  4.1.4 Validation Biomarker
  4.1.5 Other
4.2 By Type - Global Central Nervous System Biomarkers Revenue & Forecasts
  4.2.1 By Type - Global Central Nervous System Biomarkers Revenue, 2017-2022
  4.2.2 By Type - Global Central Nervous System Biomarkers Revenue, 2023-2028
  4.2.3 By Type - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Central Nervous System Biomarkers Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Central Nervous System Biomarkers Revenue & Forecasts
  5.2.1 By Application - Global Central Nervous System Biomarkers Revenue, 2017-2022
  5.2.2 By Application - Global Central Nervous System Biomarkers Revenue, 2023-2028
  5.2.3 By Application - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Central Nervous System Biomarkers Market Size, 2021 & 2028
6.2 By Region - Global Central Nervous System Biomarkers Revenue & Forecasts
  6.2.1 By Region - Global Central Nervous System Biomarkers Revenue, 2017-2022
  6.2.2 By Region - Global Central Nervous System Biomarkers Revenue, 2023-2028
  6.2.3 By Region - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Central Nervous System Biomarkers Revenue, 2017-2028
  6.3.2 US Central Nervous System Biomarkers Market Size, 2017-2028
  6.3.3 Canada Central Nervous System Biomarkers Market Size, 2017-2028
  6.3.4 Mexico Central Nervous System Biomarkers Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Central Nervous System Biomarkers Revenue, 2017-2028
  6.4.2 Germany Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.3 France Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.4 U.K. Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.5 Italy Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.6 Russia Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.7 Nordic Countries Central Nervous System Biomarkers Market Size, 2017-2028
  6.4.8 Benelux Central Nervous System Biomarkers Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Central Nervous System Biomarkers Revenue, 2017-2028
  6.5.2 China Central Nervous System Biomarkers Market Size, 2017-2028
  6.5.3 Japan Central Nervous System Biomarkers Market Size, 2017-2028
  6.5.4 South Korea Central Nervous System Biomarkers Market Size, 2017-2028
  6.5.5 Southeast Asia Central Nervous System Biomarkers Market Size, 2017-2028
  6.5.6 India Central Nervous System Biomarkers Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Central Nervous System Biomarkers Revenue, 2017-2028
  6.6.2 Brazil Central Nervous System Biomarkers Market Size, 2017-2028
  6.6.3 Argentina Central Nervous System Biomarkers Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, 2017-2028
  6.7.2 Turkey Central Nervous System Biomarkers Market Size, 2017-2028
  6.7.3 Israel Central Nervous System Biomarkers Market Size, 2017-2028
  6.7.4 Saudi Arabia Central Nervous System Biomarkers Market Size, 2017-2028
  6.7.5 UAE Central Nervous System Biomarkers Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Central Nervous System Biomarkers Major Product Offerings
  7.1.4 Merck Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Takeda Pharmaceutical
  7.2.1 Takeda Pharmaceutical Corporate Summary
  7.2.2 Takeda Pharmaceutical Business Overview
  7.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Major Product Offerings
  7.2.4 Takeda Pharmaceutical Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.2.5 Takeda Pharmaceutical Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Major Product Offerings
  7.3.4 Thermo Fisher Scientific Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Avacta Group
  7.4.1 Avacta Group Corporate Summary
  7.4.2 Avacta Group Business Overview
  7.4.3 Avacta Group Central Nervous System Biomarkers Major Product Offerings
  7.4.4 Avacta Group Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.4.5 Avacta Group Key News
7.5 Diagenic Asa
  7.5.1 Diagenic Asa Corporate Summary
  7.5.2 Diagenic Asa Business Overview
  7.5.3 Diagenic Asa Central Nervous System Biomarkers Major Product Offerings
  7.5.4 Diagenic Asa Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.5.5 Diagenic Asa Key News
7.6 Banyan Biomarkers
  7.6.1 Banyan Biomarkers Corporate Summary
  7.6.2 Banyan Biomarkers Business Overview
  7.6.3 Banyan Biomarkers Central Nervous System Biomarkers Major Product Offerings
  7.6.4 Banyan Biomarkers Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.6.5 Banyan Biomarkers Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Central Nervous System Biomarkers Major Product Offerings
  7.7.4 Eli Lilly Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Central Nervous System Biomarkers Major Product Offerings
  7.8.4 Pfizer Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Alseres Pharmaceuticals
  7.9.1 Alseres Pharmaceuticals Corporate Summary
  7.9.2 Alseres Pharmaceuticals Business Overview
  7.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Major Product Offerings
  7.9.4 Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.9.5 Alseres Pharmaceuticals Key News
7.10 Acumen pharmaceuticals
  7.10.1 Acumen pharmaceuticals Corporate Summary
  7.10.2 Acumen pharmaceuticals Business Overview
  7.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Major Product Offerings
  7.10.4 Acumen pharmaceuticals Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.10.5 Acumen pharmaceuticals Key News
7.11 EKF Diagnostics
  7.11.1 EKF Diagnostics Corporate Summary
  7.11.2 EKF Diagnostics Business Overview
  7.11.3 EKF Diagnostics Central Nervous System Biomarkers Major Product Offerings
  7.11.4 EKF Diagnostics Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.11.5 EKF Diagnostics Key News
7.12 Abiant
  7.12.1 Abiant Corporate Summary
  7.12.2 Abiant Business Overview
  7.12.3 Abiant Central Nervous System Biomarkers Major Product Offerings
  7.12.4 Abiant Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.12.5 Abiant Key News
7.13 Myriad RBM
  7.13.1 Myriad RBM Corporate Summary
  7.13.2 Myriad RBM Business Overview
  7.13.3 Myriad RBM Central Nervous System Biomarkers Major Product Offerings
  7.13.4 Myriad RBM Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.13.5 Myriad RBM Key News
7.14 Aposense
  7.14.1 Aposense Corporate Summary
  7.14.2 Aposense Business Overview
  7.14.3 Aposense Central Nervous System Biomarkers Major Product Offerings
  7.14.4 Aposense Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
  7.14.5 Aposense Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Central Nervous System Biomarkers Market Opportunities & Trends in Global Market
Table 2. Central Nervous System Biomarkers Market Drivers in Global Market
Table 3. Central Nervous System Biomarkers Market Restraints in Global Market
Table 4. Key Players of Central Nervous System Biomarkers in Global Market
Table 5. Top Central Nervous System Biomarkers Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Central Nervous System Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Central Nervous System Biomarkers Revenue Share by Companies, 2017-2022
Table 8. Global Companies Central Nervous System Biomarkers Product Type
Table 9. List of Global Tier 1 Central Nervous System Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Central Nervous System Biomarkers Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Central Nervous System Biomarkers Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Central Nervous System Biomarkers Product Offerings
Table 32. Merck Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 33. Takeda Pharmaceutical Corporate Summary
Table 34. Takeda Pharmaceutical Central Nervous System Biomarkers Product Offerings
Table 35. Takeda Pharmaceutical Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Central Nervous System Biomarkers Product Offerings
Table 38. Thermo Fisher Scientific Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 39. Avacta Group Corporate Summary
Table 40. Avacta Group Central Nervous System Biomarkers Product Offerings
Table 41. Avacta Group Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 42. Diagenic Asa Corporate Summary
Table 43. Diagenic Asa Central Nervous System Biomarkers Product Offerings
Table 44. Diagenic Asa Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 45. Banyan Biomarkers Corporate Summary
Table 46. Banyan Biomarkers Central Nervous System Biomarkers Product Offerings
Table 47. Banyan Biomarkers Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Central Nervous System Biomarkers Product Offerings
Table 50. Eli Lilly Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Central Nervous System Biomarkers Product Offerings
Table 53. Pfizer Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 54. Alseres Pharmaceuticals Corporate Summary
Table 55. Alseres Pharmaceuticals Central Nervous System Biomarkers Product Offerings
Table 56. Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 57. Acumen pharmaceuticals Corporate Summary
Table 58. Acumen pharmaceuticals Central Nervous System Biomarkers Product Offerings
Table 59. Acumen pharmaceuticals Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 60. EKF Diagnostics Corporate Summary
Table 61. EKF Diagnostics Central Nervous System Biomarkers Product Offerings
Table 62. EKF Diagnostics Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 63. Abiant Corporate Summary
Table 64. Abiant Central Nervous System Biomarkers Product Offerings
Table 65. Abiant Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 66. Myriad RBM Corporate Summary
Table 67. Myriad RBM Central Nervous System Biomarkers Product Offerings
Table 68. Myriad RBM Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
Table 69. Aposense Corporate Summary
Table 70. Aposense Central Nervous System Biomarkers Product Offerings
Table 71. Aposense Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Central Nervous System Biomarkers Segment by Type in 2021
Figure 2. Central Nervous System Biomarkers Segment by Application in 2021
Figure 3. Global Central Nervous System Biomarkers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Central Nervous System Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Central Nervous System Biomarkers Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Central Nervous System Biomarkers Revenue in 2021
Figure 8. By Type - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 9. By Application - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 10. By Region - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 11. By Country - North America Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 12. US Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 16. Germany Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 17. France Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 24. China Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 28. India Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 30. Brazil Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue Market Share, 2017-2028
Figure 33. Turkey Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takeda Pharmaceutical Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Avacta Group Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Diagenic Asa Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Banyan Biomarkers Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Acumen pharmaceuticals Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. EKF Diagnostics Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Abiant Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Myriad RBM Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Aposense Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)